Polaryx Therapeutics, Inc. Common Stock
€2.167
EUR
Last updated on --.
24h volume742.05K
24h highest2.3392 EUR
24h lowest1.7802 EUR
24h Price movement-2.33%


PLYX recent prices
24 Hours
-2.33%-€0.0516
30 days
-53.82%-€2.606
60 days
-60.67%-€3.449
90 days
-14.75%-€0.387
Key data
Previous close2.2188 EUR
Market cap112.37M EUR
Volume742.05K
P/E ratio--
Dividend yield (TTM)--
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)--
Net income (FY)--
Revenue (FY)--
Last report date--
About Polaryx Therapeutics, Inc. Common Stock
HeadquartersPARAMUS
Listed onNasdaq
PLYX conversion tables
| 0.5 PLYX | 1.083 EUR |
| 1 PLYX | 2.167 EUR |
| 5 PLYX | 10.83 EUR |
| 10 PLYX | 21.67 EUR |
| 0.5 EUR | 0.23071 PLYX |
| 1 EUR | 0.46142 PLYX |
| 5 EUR | 2.307 PLYX |
| 10 EUR | 4.614 PLYX |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
PLYX is trading at €2.167, -2.33% over the last 24 hours. Track live moves on the price chart at the top of this page.
The PLYX stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. PLYX is currently trading at €2.167, -2.33% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on PLYX price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. PLYX's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from PLYX; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against PLYX's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Polaryx Therapeutics, Inc. Common Stock's market cap is currently 112.37M EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume742.05K
24h highest2.3392 EUR
24h lowest1.7802 EUR
24h Price movement-2.33%


Start trade with PLYX Perpetual
Sign up to trade
















